Tricin

CAS No. 520-32-1

Tricin( —— )

Catalog No. M24494 CAS No. 520-32-1

Tricin can inhibit human cytomegalovirus (HCMV) replication by inhibiting CDK9. Tricin inhibits the proliferation and invasion of C6 glioma cells via the upregulation of focal-adhesion-finase (FAK)-targeting microRNA-7.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 93 In Stock
5MG 123 In Stock
10MG 180 In Stock
25MG 359 In Stock
50MG 576 In Stock
100MG 816 In Stock
200MG Get Quote In Stock
500MG 1628 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Tricin
  • Note
    Research use only, not for human use.
  • Brief Description
    Tricin can inhibit human cytomegalovirus (HCMV) replication by inhibiting CDK9. Tricin inhibits the proliferation and invasion of C6 glioma cells via the upregulation of focal-adhesion-finase (FAK)-targeting microRNA-7.
  • Description
    Tricin can inhibit human cytomegalovirus (HCMV) replication by inhibiting CDK9. Tricin inhibits the proliferation and invasion of C6 glioma cells via the upregulation of focal-adhesion-finase (FAK)-targeting microRNA-7.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    CDK
  • Recptor
    CDK9|CMV
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    520-32-1
  • Formula Weight
    330.29
  • Molecular Formula
    C17H14O7
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:125 mg/mL (378.46 mM; Need ultrasonic)
  • SMILES
    O=C1C=C(C2=CC(OC)=C(O)C(OC)=C2)OC3=CC(O)=CC(O)=C13
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Tricin derivatives as anti-inflammatory and anti-allergic constituents from the aerial part of Zizania latifolia.Biosci Biotechnol Biochem. 2015 May;79(5):700-6.
molnova catalog
related products
  • CCT251545

    CCT251545 is a potent, orally bioavailable inhibitor of Wnt signaling with IC50 of 5 nM, also is a potent and selective chemical probe for CDK8 and CDK19 with >100-fold selectivity over 291 other kinases; potently inhibits reporter-based readouts of basal WNT pathway activity in LS174T and SW480 cells in the absence of WNT ligand with IC50 of 23 and 190 nM, respectively.

  • XY028-140

    XY028-140 is a selective CDK4/CDK6 degrade and inhibits both CDK4/6 expression and activity in cancer cells. XY028-140 is a PROTAC connected by ligands for Cereblon and CDK.

  • VMY-1-103

    A novel dansylated analog of purvalanol B, and a CDK inhibitor that inhibits cell cycle progression and proliferation in prostate and breast cancer cells more effectively than purvalanol B.